A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to evaluate the effects of both single and multiple dose drug levels of MYK-224 in healthy adult Japanese participants.

Key facts

Study ID

NCT05405543

Run by

Bristol-Myers Squibb

People needed

36

Starts

2022-07-12

Expected to finish

2022-12-09

Last updated by the study team

2023-01-13

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy as determined by medical history, physical examination, vital signs,12-lead electrocardiogram and routine laboratory assessments
• Must have documented left Ventricular Ejection Fraction (LVEF) ≥60% (2D biplane Simpson's Method) at screening as determined by the echocardiographic core laboratory.

You may not qualify if…

• Any acute or chronic medical illness
• History of heart disease
• Other protocol-defined inclusion/exclusion criteria apply

Where it is running

• Local Institution - 0001 — Anaheim, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.